Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the efficacy, immunogenicity and safety of S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine in infants and children aged from 6 months to 5 years.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
NCT05959616 · Shigellosis
NCT06615375 · Shigellosis
NCT06838195 · Dysentery, Dysentery, Shigella
NCT05182749 · Shigellosis
NCT03854929 · Dysentery, Shigella, Shigellosis, and more
Hezhou Center for Disease Control and Prevention
Hezhou, Guangxi
Luzhai Center for Disease Control and Prevention
Luzhai, Guangxi
Sanjiang Center for Disease Control and Prevention
Sanjiang, Guangxi
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions